Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control.

od Stanbridge, E J, Wilkinson, J
Izdano 1978

Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation.

od Latham, K M, Stanbridge, E J
Izdano 1990

Infection of mouse lymphoblastoid cell lines with Mycoplasma hyorhinis: complex nature of mycoplasma-host cell interactions.

od Butler, G H, Stanbridge, E J
Izdano 1983

Anchorage-independent growth of normal human fibroblasts.

od Peehl, D M, Stanbridge, E J
Izdano 1981

Effects of mycoplasma contamination on phenotypic expression of mitochondrial mutants in human cells.

od Doersen, C J, Stanbridge, E J
Izdano 1981

Cytoplasmic inheritance of erythromycin resistance in human cells.

od Doersen, C J, Stanbridge, E J
Izdano 1979

Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer.

od Rodriguez-Alfageme, C, Stanbridge, E J, Astrin, S M
Izdano 1992

Expression of the alpha subunit of human chorionic gonadotropin is specifically correlated with tumorigenic expression in human cell hybrids.

od Stanbridge, E J, Rosen, S W, Sussman, H H
Izdano 1982

Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.

od Saxon, P J, Srivatsan, E S, Stanbridge, E J
Izdano 1986

Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells.

od Newstein, M, Stanbridge, E J, Casey, G, Shank, P R
Izdano 1990

Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane.

od Tao, W, Wilkinson, J, Stanbridge, E J, Berns, M W
Izdano 1987

Selective growth inhibition by glycogen synthase kinase-3 inhibitors in tumorigenic HeLa hybrid cells is mediated through NF-κB-dependent GLUT3 expression

od Watanabe, M, Abe, N, Oshikiri, Y, Stanbridge, E J, Kitagawa, T
Izdano 2012

Purification and partial characterization of the principal deoxyribonucleic acid polymerase from Mycoplasmatales.

od Mills, L B, Stanbridge, E J, Sedwick, W D, Korn, D
Izdano 1977

Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors.

od Kaluzová, M, Pastoreková, S, Svastová, E, Pastorek, J, Stanbridge, E J, Kaluz, S
Izdano 2001

Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.

od Geiser, A G, Der, C J, Marshall, C J, Stanbridge, E J
Izdano 1986

Human chromosome 15 confers partial complementation of phenotypes to xeroderma pigmentosum group F cells.

od Saxon, P J, Schultz, R A, Stanbridge, E J, Friedberg, E C
Izdano 1989

Isolation and characterization of the QM promoter.

od Farmer, A A, Johnsen, J I, Loftus, T M, Smith, K P, Stanbridge, E J
Izdano 1996

Selective transfer of individual human chromosomes to recipient cells.

od Saxon, P J, Srivatsan, E S, Leipzig, G V, Sameshima, J H, Stanbridge, E J
Izdano 1985

The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells.

od Dowdy, S F, Lai, K M, Weissman, B E, Matsui, Y, Hogan, B L, Stanbridge, E J
Izdano 1991

Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

od Plattner, R, Anderson, M J, Sato, K Y, Fasching, C L, Der, C J, Stanbridge, E J
Izdano 1996